Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FY.2.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.13SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.11SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.4.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FD.2.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FP.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FD.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FG.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.19SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GA.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.67SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.2.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.88SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CM.10SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.2.11SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BN.1.5.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.25SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
EG.4.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.27SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
DV.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CH.1.1.10SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CH.1.1.26SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
DV.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CH.1.1.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.32SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
DS.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.15SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CV.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBKSYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.14.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBK.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CM.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.16SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GK.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.24.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GK.1.8.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GE.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
EG.5.1.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HK.3.2.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HK.13.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.20.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HK.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HK.8.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.19.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GE.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used